|
Español
English
|
Dadun >
Browsing by Author Odero, M.D. (María D.)
Showing results 32 to 46 of 46
| Issue Date | Title | Author(s) | | 2004 | Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells | Lahortiga, I. (Idoya); Aguirre, X. (Xavier); Belloni, E. (E.); Vazquez, I. (Iria); Larrayoz, M.J. (María J.); Gasparini, P. (P.); Lo-Coco, F. (Francesco); Pelicci, P.G. (Pier G.); Calasanz, M.J. (Maria José); Odero, M.D. (María D.) |
| 2003 | Molecular cytogenetic characterization of breakpoints in 19 patients with hematologic malignancies and 12p unbalanced translocations | Odero, M.D. (María D.); Carlson, K. (K.); Lahortiga, I. (Idoya); Calasanz, M.J. (Maria José); Rowley, J.D. (Janet D.) |
| 2004 | Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements | Lahortiga, I. (Idoya); Vazquez, I. (Iria); Aguirre, X. (Xavier); Larrayoz, M.J. (María J.); Vizmanos, J.L. (José Luis); Gozzetti, A. (A.); Calasanz, M.J. (Maria José); Odero, M.D. (María D.) |
| 2007 | Multicolor interphase cytogenetics for the study of plasma cell dyscrasias | Saez, B. (Borja); Martin-Subero, J.I. (José Ignacio); Odero, M.D. (María D.); Prosper, F. (Felipe); Cigudosa, J.C. (Juan Cruz); Schoch, R. (Robert); Calasanz, M.J. (Maria José); Siebert, R. (Reiner) |
| 2001 | New cytogenetic prognostic markers in breast cancer | Zudaire, I. (Isabel); Odero, M.D. (María D.); Caballero, M.C. (M.C.); Valenti, C. (C.); Martinez-Peñuela, J.M. (J.M.); Calasanz, M.J. (Maria José) |
| 2004 | NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder | Vizmanos, J.L. (José Luis); Novo, F.J. (Francisco Javier); Roman, J.P. (José P.); Baxter, E.J. (E.J.); Lahortiga, I. (Idoya); Larrayoz, M.J. (María J.); Odero, M.D. (María D.); Giraldo, P. (P.); Calasanz, M.J. (Maria José); Cross, N.C.P. (Nicholas C.P.) |
| 2003 | NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15) | Lahortiga, I. (Idoya); Vizmanos, J.L. (José Luis); Aguirre, X. (Xavier); Vazquez, I. (Iria); Cigudosa, J.C. (Juan Cruz); Larrayoz, M.J. (María J.); Sala, F. (Francisco); Gorosquieta, A. (A.); Perez-Equiza, K. (Katy); Calasanz, M.J. (Maria José); Odero, M.D. (María D.) |
| 2005 | NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2 | Lahortiga, I. (Idoya); Belloni, E. (E.); Vazquez, I. (Iria); Aguirre, X. (Xavier); Larrayoz, M.J. (María J.); Vizmanos, J.L. (José Luis); Valgañon, M. (Mikel); Zudaire, I. (Isabel); Saez, B. (Borja); Mateos, M.C. (María C.); Di-Fiore, P.P. (Pier Paolo); Calasanz, M.J. (Maria José); Odero, M.D. (María D.) |
| 2012 | Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia | Cristobal, I. (Ion); Garcia-Orti, L. (Laura); Cirauqui, C. (Cristina); Cortes-Lavaud, X. (Xabier); Garcia-Sanchez, M.A. (María A.); Calasanz, M.J. (María José); Odero, M.D. (María D.) |
| 2005 | p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV | Valgañon, M. (Mikel); Giraldo, P. (P.); Aguirre, X. (Xavier); Larrayoz, M.J. (María J.); Rubio-Martinez, A. (Araceli); Rubio-Felix, D. (Daniel); Calasanz, M.J. (Maria José); Odero, M.D. (María D.) |
| 2004 | Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion | Vizmanos, J.L. (José Luis); Larrayoz, M.J. (María J.); Vazquez, I. (Iria); Odero, M.D. (María D.); Hernandez, R. (Roberto); Lahortiga, I. (Idoya); Novo, F.J. (Francisco Javier); Ardanaz, M.T. (M.T.); Calasanz, M.J. (Maria José) |
| 2003 | Secondary myelodysplastic syndrome after treatment for promyelocytic leukemia: clinical and genetic features of two cases | Panizo, C. (Carlos); Patiño, A. (Ana); Lecumberri, R. (Ramón); Calasanz, M.J. (Maria José); Odero, M.D. (María D.); Bendandi, M. (Maurizio); Rocha, E. (Eduardo) |
| 2010 | Silencing of hsa-miR-124 by EVI1 in cell lines and patients with acute myeloid leukemia | Vazquez, I. (Iria); Maicas, M. (Miren); Marcotegui, N. (Nerea); Conchillo, A. (Ana); Guruceaga, E. (Elizabeth); Roman-Gomez, J. (José); Calasanz, M.J. (Maria José); Aguirre, X. (Xavier); Prosper, F. (Felipe); Odero, M.D. (María D.) |
| 2007 | Simultaneous translocations of FGFR3/MMSET and CCND1 into two different IGH alleles in multiple myeloma: lack of concurrent activation of both proto-oncogenes | Saez, B. (Borja); Martin-Subero, J.I. (José Ignacio); Lahortiga, I. (Idoya); Largo, C. (Cristina); Larrayoz, M.J. (María J.); Odero, M.D. (María D.); Prosper, F. (Felipe); Cigudosa, J.C. (Juan Cruz); Siebert, R. (Reiner); Calasanz, M.J. (Maria José) |
| 2003 | t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia | Vizmanos, J.L. (José Luis); Larrayoz, M.J. (María J.); Lahortiga, I. (Idoya); Floristan, F. (Filomena); Alvarez, C. (Carmen); Odero, M.D. (María D.); Novo, F.J. (Francisco Javier); Calasanz, M.J. (Maria José) |
Showing results 32 to 46 of 46
|
